H J Weinstein
Overview
Explore the profile of H J Weinstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1016
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OBrien M, Cao X, Pounds S, Dahl G, Raimondi S, Lacayo N, et al.
Leukemia
. 2012 Aug;
27(3):731-4.
PMID: 22918081
No abstract available.
2.
Ravindranath Y, Chang M, Steuber C, Becton D, Dahl G, Civin C, et al.
Leukemia
. 2005 Sep;
19(12):2101-16.
PMID: 16136167
From 1981 to 2000, a total of 1823 children with acute myeloid leukemia (AML) enrolled on four consecutive Pediatric Oncology Group (POG) clinical trials. POG 8101 demonstrated that the induction...
3.
Ge Y, Jensen T, James S, Becton D, Massey G, Weinstein H, et al.
Leukemia
. 2002 Oct;
16(11):2339-41.
PMID: 12399985
No abstract available.
4.
Laver J, Mahmoud H, Pick T, Hutchinson R, Weinstein H, Schwenn M, et al.
Leuk Lymphoma
. 2001 Nov;
42(3):399-405.
PMID: 11699405
The Pediatric Oncology Group (POG) adopted a histology-based approach to the management of pediatric non-Hodgkin's lymphomas (NHL) utilizing the National Cancer Institute Working Formulation for Clinical Usage. Patients with diffuse...
5.
Bell B, Chang M, Weinstein H
Med Pediatr Oncol
. 2001 Aug;
37(2):103-7.
PMID: 11496347
Background: Homoharringtonine (HHT) is a plant alkaloid that is derived from a Chinese evergreen tree. Its mechanism of action is thought to be by inhibition of protein, DNA, and RNA...
6.
Friedmann A, Weinstein H
Oncologist
. 2000 Aug;
5(4):321-8.
PMID: 10965000
Acute lymphoblastic leukemia (ALL) is the most common cancer in children and is among the most curable of the pediatric malignancies. Many clinical, biological, genetic, and molecular features have been...
7.
Grupp S, Stern J, Bunin N, Nancarrow C, Ross A, Mogul M, et al.
J Clin Oncol
. 2000 Jul;
18(13):2567-75.
PMID: 10893288
Purpose: Advances in chemotherapy and supportive care have slowly improved survival rates for patients with high-risk neuroblastoma. The focus of many of these chemotherapeutic advances has been dose intensification. In...
8.
Dahl G, Lacayo N, Brophy N, Weinstein H, Chang M, Sikic B, et al.
J Clin Oncol
. 2000 Apr;
18(9):1867-75.
PMID: 10784627
Purpose: To determine the remission rate and toxicity of mitoxantrone, etoposide, and cyclosporine (MEC) therapy, multidrug resistance-1 (MDR1) status, and steady-state cyclosporine (CSA) levels in children with relapsed and/or refractory...
9.
McLean T, Hertel C, Young M, Marcus K, Schizer M, Gebhardt M, et al.
J Pediatr Hematol Oncol
. 1999 Dec;
21(6):486-93.
PMID: 10598659
The outcome for 82 pediatric patients with Ewing sarcoma (ES) and primitive neuroectodermal tumor (PNET) of bone is reported; the patients were treated at the Dana-Farber Cancer Institute (DFCI) and...
10.
Raimondi S, Chang M, Ravindranath Y, Behm F, Gresik M, Steuber C, et al.
Blood
. 1999 Nov;
94(11):3707-16.
PMID: 10572083
We determined the type and frequency of chromosomal aberrations in leukemic cells of 478 children diagnosed with acute myeloid leukemia and enrolled in the Pediatric Oncology Group study 8821. Of...